Ambu

Share Issue/Capital Change • Apr 7, 2011

Company Announcement no. 12 10/11 7 April 2011

Employee share issue completed

As notified in Company Announcement no. 10-2010/11 of 7 February 2011, Ambu's Board of Directors have decided to offer the employees the opportunity to subscribe for B shares in Ambu A/S in accordance with the authorisation from the ordinary general meeting of December 2010.

The share issue has now been completed, and the employees have subscribed for 31,782 B shares (nominally DKK 317,820) – corresponding to 67 per cent of the maximum number of B shares available for subscription. The Group's employees in China have not been able to subscribe for shares in connection with the share issue due to legal restrictions in that country. Following this issue, the number of shares in Ambu A/S totals 11,908,080 corresponding to a share capital of DKK 119,080,800.

The capital increase will be reported to the Danish Commerce and Companies Agency for registration, after which the new B shares are expected to be admitted for listing on the Copenhagen Stock Exchange as soon as possible.

Further information: Lars Marcher, CEO, phone +45 5136 2490, e-mail: lm@ambu.com

Ambu develops, produces and markets diagnostic and life-supporting devices to hospitals and rescue services. Ambu has three business areas: Airway Management, Patient Monitoring & Diagnostics and Emergency Care. Ambu's high-quality products are innovative and unique. Ambu has a favourable market position in its chosen focus areas.Ambu's products are sold worldwide. Exports account for 98% of sales, and sales are handled via Ambu's foreign subsidiaries or via distributors. Ambu has approx. 1,600 employees, of whom 200 work in Denmark and 1,400 abroad.